This Eye Connect initiative highlights the importance of screening, diagnosing, and treating diabetic retinopathy (DR) and diabetic macular edema (DME) in patients with diabetes. This multidisciplinary CE collection of expert faculty discussions and patient cases targets the collaborative goal of primary care providers (PCPs) (ie, internists, family practitioners [FPs], nurse practitioners [NPs], and PAs), endocrinologists, and eye care specialists (optometrists, comprehensive ophthalmologists, residents, retina specialists, and retina fellows) of achieving optimal eye health for patients with diabetes.

Expires May 31, 2023

Test your knowledge about newest guideline recommendations, current evidence, and strategies to individualize treatment for patients with T2D using GLP-1 RAs by building your own case studies. This will help your patients achieve A_1C targets, particularly those with comorbidities including obesity, cardiovascular disease, NAFLD/NASH, transplants, PCOS and more!  Additionally, this will help you identify various social determinants of health (SDoH) that may be unrecognizable and help you direct your patients in changing important modifiable behaviors (like sleep, stress, smoking cessation, and alcohol use).

Expires October 27, 2023

What role might novel agents play, and how can endocrinologists engage with their patients to make better therapeutic choices? During the session, previously hosted at the 58th EASD Annual Meeting, experts will explain the incretin effect and the roles of GLP-1 and GIP, as well as the potential benefits of agonism of multiple receptors that affect energy homeostasis; they will also interpret the clinical implications of new and emerging data for the first-in-class dual GLP-1 and GIP agonist. Case studies will identify individuals with T2D who may benefit from earlier treatment intensification to improve overall health and delineate practical considerations to help individuals with T2D achieve optimal outcomes.

Expires October 29, 2023